This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica...tions are available that provide a background to pharmacovigilance and, as far as possible, that material will not be repeated here. Health officials, planners, the staff of Pharmacovigilance Centres, public health teams and all health workers should become familiar with these publications, which are: • Safety of Medicines: A guide to detecting and reporting adverse drug reactions
more
PLOS ONE | https://doi.org/10.1371/journal.pone.0196239 April 23, 2018
Recommandations pour une approche de santé publique
Research Article
PLOS ONE | https://doi.org/10.1371/journal.pone.0192791 February 15, 2018
Policy Guidelines for Health Facilities
Research Article
PLOS ONE | DOI:10.1371/journal.pone.0164619 October 13, 2016
Recommendations, resources and references
A publication of the Southern African HIV Clinicians Society
HIV Treatment
Policy Brief
July 2017
Supplement Article
J Acquir Immune Defic Syndr Volume 75, Supplement 2, June 1, 2017 www.jaids.com
Yu et al. BMC Public Health (2018) 18:825 https://doi.org/10.1186/s12889-018-5731-z
Research Article
O presente Guião de Bolso referente ao Tratamento antiretroviral e de infecções oportunistas
do adulto, adolescente e criança é um instrumento de grande utilidade para os profissionais de saúde, em especial os envolvidos no tratamento dos pacientes infectados pelo HIV em Moçambique. O Guião... salvaguarda uma abordagem correcta, atempada e padronizada no atendimento aos pacientes com HIV/SIDA, garantindo o uso racional e cientificamente fundamentado dos escassos recursos existentes.
more
Journal of the International AIDS Society Vol. 21 (2018) e25133
Many prevention of mother-to-child HIV transmission programmes across Africa initiate HIV-infected (HIV positive) pregnant women on lifelong antiretroviral therapy (ART) on the first day of antenatal care (“same-day” initiation...). However, there are concerns that same-day initiation may limit patient preparation before starting ART and contribute to subsequent non-adherence, disengagement from care and raised viral load. We examined if same-day initiation was associated with viral suppression and engagement in care during pregnancy.
The data suggest that same-day ART initiation during pregnancy is not associated with lower levels of engagement in care or viral suppression through 12 months post-delivery in this setting, providing reassurance to ART programmes implementing Option B+.
https://doi.org/10.1002/jia2.25133
more